Literature DB >> 12747553

Remodelling of the host cell RNA splicing machinery during an adenovirus infection.

G Akusjärvi1, J Stévenin.   

Abstract

Adenovirus makes extensive use of RNA splicing to produce a complex set of spliced mRNAs during virus replication. All transcription units, except pIX and IVa2, encode multiple alternatively spliced mRNAs. The accumulation of viral mRNAs is subjected to a temporal regulation, a mechanism that ensures that proteins that are needed at certain stages of the viral life cycle are produced. The complex interaction between host cell RNA splicing factors and viral regulatory elements has been studied intensely during the last decade. Such studies have begun to produce a picture of how adenovirus remodels the host cell RNA splicing machinery to orchestrate the shift from the early to the late profile of viral mRNA accumulation. Recent progress has to a large extent focused on the mechanisms regulating E1A and L1 alternative splicing. Here we will review the current knowledge of cis-acting sequence element, trans-acting factors and mechanisms controlling E1A and L1 alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747553     DOI: 10.1007/978-3-662-05597-7_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  14 in total

1.  The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.

Authors:  Vita Dauksaite; Göran Akusjärvi
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 2.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

3.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Dynamic interactions between Bombyx mori nucleopolyhedrovirus and its host cells revealed by transcriptome analysis.

Authors:  Jian Xue; Nan Qiao; Wei Zhang; Ruo-Lin Cheng; Xiao-Qin Zhang; Yan-Yuan Bao; Yi-Peng Xu; Lin-Zhu Gu; Jing-Dong Jackie Han; Chuan-Xi Zhang
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 5.  Reevaluation of the reliability and usefulness of the somatic homologous recombination reporter lines.

Authors:  Bekir Ülker; Carl Maximilian Hommelsheim; Tobias Berson; Stefan Thomas; Balakumaran Chandrasekar; Ahmet Can Olcay; Kenneth Wayne Berendzen; Lamprinos Frantzeskakis
Journal:  Plant Cell       Date:  2012-11-09       Impact factor: 11.277

6.  Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members.

Authors:  Huiwen Wang; Jill Molfenter; Hui Zhu; Hua Lou
Journal:  Nucleic Acids Res       Date:  2010-02-16       Impact factor: 16.971

Review 7.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

Review 8.  Regulation of human adenovirus alternative RNA splicing by the adenoviral L4-33K and L4-22K proteins.

Authors:  Roberta Biasiotto; Göran Akusjärvi
Journal:  Int J Mol Sci       Date:  2015-01-28       Impact factor: 5.923

9.  Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.

Authors:  Rui Wang; Ronald G Crystal; Neil R Hackett
Journal:  BMC Mol Biol       Date:  2009-11-17       Impact factor: 2.946

10.  An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.

Authors:  Claire A Schreiber; Toshie Sakuma; Yoshihiro Izumiya; Sara J Holditch; Raymond D Hickey; Robert K Bressin; Upamanyu Basu; Kazunori Koide; Aravind Asokan; Yasuhiro Ikeda
Journal:  PLoS Pathog       Date:  2015-08-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.